Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02757638 · ClinicalTrials.gov registry record · NA
Omics Profiling of Weight Loss With Bariatric Surgery
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02757638: Completed NA study, sponsored by Texas A&M University.
NCT02757638 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02757638, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Understanding how foods and nutrients are digested, absorbed and metabolized when weight is stable and during weight loss induced by bariatric surgery procedure using the technologies of genomics, transcriptomics, proteomics, metabolomics and fluxomics ("omics") will enable generation of new hypotheses that could explain the inter-individual differences in weight loss and could lead to optimization and individualization of therapies designed to lose weight.
Primary Outcome
Change in whole-body protein synthesis rate after intake of meal
Interventions
- OTHER Stable isotope infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-02-25 |
| Est. Completion | 2018-06-29 |
| Phase | NA |
What the finished NCT02757638 record still lists
NCT02757638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Stable isotope infusion is the first listed.
NCT02757638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02757638 about?
NCT02757638 is a clinical study titled "Omics Profiling of Weight Loss With Bariatric Surgery". Understanding how foods and nutrients are digested, absorbed and metabolized when weight is stable and during weight loss induced by bariatric surgery procedure using the technologies of genomics, transcriptomics, proteomics, metabolomics and fluxomics ("omics") will enable generation of new hypothe...
What is the current status of trial NCT02757638?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-02-25. Estimated completion is 2018-06-29.
What interventions are being tested in trial NCT02757638?
The interventions under investigation include: Stable isotope infusion (OTHER).
Who is sponsoring clinical trial NCT02757638?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02757638's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI